Aspirin Use Found to Lower Risk of Pancreatic Cancer

Some inmates frustrated by lack of treatment for hepatitis C
January 23, 2017
Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery
January 24, 2017
Show all

Aspirin Use Found to Lower Risk of Pancreatic Cancer

Aspirin lowers the risk for pancreatic cancer.

The regular use of aspirin lowers the risk for pancreatic cancer by almost 50 percent, a new study in China led by the Yale School of Public Health finds.

Researchers studied patients with newly diagnosed pancreatic cancer at 37 Shanghai hospitals from December 2006 to January 2011. The 761 patients were interviewed in person about their use of aspirin per day or week and their ages when the use started and stopped. They were matched with control patients identified from the Shanghai Residents Registry.

“This is a significant finding and helps to understand the development of pancreatic cancer,” said lead author Harvey Risch, M.D., Ph.D., professor at the Yale School of Public Health in the Department of Chronic Disease Epidemiology. “There is evidence accumulating that aspirin use slows the development of precancerous changes in the pancreas.”

Read full article: Aspirin Use Found to Lower Risk of Pancreatic Cancer

Read Full Article: Aspirin Use Found to Lower Risk of Pancreatic Cancer

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.